ROYAL BANK OF CANADA - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is ASTWS and the CUSIP is 04624N115. A total of 35 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2017$09
+12.5%
0.00%
Q1 2017$080.0%0.00%
Q4 2016$080.0%0.00%
Q3 2016$08
-76.5%
0.00%
Q2 2016$0340.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 328,205$164,0000.03%
Manatuck Hill Partners, LLC 75,000$38,0000.02%
CSS LLC/IL 129,837$65,0000.00%
JPMORGAN CHASE & CO 264$00.00%
ROYAL BANK OF CANADA 9$00.00%
Creative Planning 126$00.00%
VANGUARD GROUP INC 89,777$45,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 142$00.00%
Virtu KCG Holdings LLC 23,007$12,0000.00%
UBS Group AG 3,870$2,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders